Contribution of the ARLTS1 Gene to Prostate Cancer Susceptibility (Pehmeäkantinen kirja)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 196ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
+ / - Hover over image to Zoom
Verkkokaupassa:
41,39
Saatavuus:

Toimitusaika 3 - 14 arkipäivää

Toimitustavat:
Nouto myymälästä tai pakettiautomaatista alk. 0 €
Toimitus kotiin alk. 2,95 €
Prostate cancer is the most common malignancy among men in industrialised countries, including Finland. It is a heterogeneous disease with definitive risk factors that include age, ethnic origin and family history. In Finland, the incidence of prostate cancer is 89.4/100,000 and in 2010, 4,697 new prostate cancer cases were diagnosed. Despite extensive research over the last decade, the aetiological risk factors and genes underlying the genetic susceptibility to prostate cancer remain largely unclear, which has hampered effective prevention and the development of better treatments.
Kun ostat verkkokaupasta:
  1. 1 Laskulla jopa 60 päivää korotonta maksuaikaa.
  2. 2 Yli 65€ ostoista toimitus veloituksetta myymälään tai pakettiautomaattiin.
  3. 3 Bonus ostoista jopa 5 %
  4. 4 Tuotteilla ilmainen palautusoikeus 14 päivän ajan.